Rezolute, Inc. (RZLT) Stock Price, News, Quote & History

Rezolute to Participate in Upcoming Investor Conferences

Investors can request one-on-one meetings with Rezolute executives at both events.

Rezolute Announces Completion of Enrollment in Phase 3 upLIFT Study of Ersodetug in Tumor Hyperinsulinism

Rezolute Completes Enrollment In Open-Label Phase 3 Study Of Ersodetug In Tumor HI; Topline Data Expected In Mid-December 2026

This NetApp Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday

Lake Street Maintains Buy on Rezolute, Raises Price Target to $12

Citizens Maintains Market Outperform on Rezolute, Raises Price Target to $15

This Boyd Gaming Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday

Cantor Fitzgerald Upgrades Rezolute to Overweight

Rezolute Gets FDA Nod For Pre-BLA Meeting Despite Phase 3 Miss — Retail Expects ‘Huge Rerating’

Rezolute Says FDA Recommends Pre-BLA Meeting for Congenital Hyperinsulinism Treatment

Rezolute Announces FDA Recommendation to Hold a Pre-BLA Meeting as a Precursor to Submitting a Biologics License Application (BLA) for Congenital Hyperinsulinism

Sector Update: Healthcare Stocks Softer Late Afternoon

Rezolute FDA Review Continues After Phase 3 sunRIZE Study Missed Primary Endpoint